COVID-19 shots.Europe’s drugs regulator, seeking to ensure proper treatment, highlighted the International Society on Thrombosis and Haemostasis (ISTH) interim guidance.
In April, the ISTH concluded “management should be initiated with non-heparin anticoagulation upon suspicion” of vaccine-linked clotting and low platelets.
Don’t ignore the symptoms, says B.C. man who survived blood clot linked to AstraZeneca The EMA move underscoring the ISTH guidelines is in line with recommendations of the U.S.